Geometric control of myogenic cell fate

International Journal of Nanomedicine

Volumn 1, Issue 2, 2006, Pages 203-212

  de Juan Pardo, Elena M ^a   Hoang, Mike Bao Trong ^a   Conboy, Irina M ^a  

^a University of California at Berkeley   (United States)

Author keywords

ECM; Myoblast; Myogenic cell fate; Myotube; Satellite cell

Indexed keywords

SCLEROPROTEIN; SIGNAL PEPTIDE;

ANIMAL; ARTICLE; C57BL MOUSE; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; METHODOLOGY; MOUSE; MUSCLE CELL; MYOBLAST; PHYSIOLOGY; TISSUE ENGINEERING;

ANIMALS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELLS, CULTURED; EXTRACELLULAR MATRIX PROTEINS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICE, INBRED C57BL; MUSCLE FIBERS; MYOBLASTS; TISSUE ENGINEERING;

EID: 34548652383     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/nano.2006.1.2.203     Document Type: Article

References (42)

1. Armand AS, Della GB, Launay T, et al. 2003. Expression and neural control of follistatin vs myostatin genes during regeneration of mouse soleus. Dev Dyn, 227:256-65.
2. Bockhold KJ, Rosenblatt JD, Partridge TA. 1998. Aging normal and dystrophic mouse muscle: analysis of myogenicity in cultures of living single fibers. Muscle Nerve, 21:173-83.
3. Bodine SC, Stitt TN, Gonzalez M, et al. 2001. Akt/mTOR pathway is a crucial regulator of skeletal muscle hypertrophy and can prevent muscle atrophy in vivo. Nat Cell Biol, 3:1014-19.
4. Chakravarthy MV, Fiorotto ML, Schwartz RJ, et al. 2001. Long-term insulin-like growth factor-I expression in skeletal muscles attenuates the enhanced in vitro proliferation ability of the resident satellite cells in transgenic mice. Mech Ageing Dev, 122:1303-20.
5. Conboy IM, Conboy MJ, Smythe GM, et al. 2003. Notch-mediated restora-tion of regenerative potential to aged muscle. Science, 302:1575-7.
6. Conboy IM, Conboy MJ, Wagers AJ, et al. 2005. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature, 433:760-4.
7. Conboy IM, Rando TA. 2002. The regulation of Notch signaling controls satellite cell activation and cell fate determination in postnatal myogenesis. Dev Cell, 3:397-409.
8. Conboy IM, Rando TA. 2005. Aging, stem cells and tissue regeneration: lessons from muscle. Cell Cycle, 4:407-10.
9. Derynck R, Zhang YE. 2003. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature, 425:577-84.
10. Disatnik MH, Boutet SC, Lee CH, et al. 2002. Sequential activation of individual PKC isozymes in integrin-mediated muscle cell spreading: a role for MARCKS in an integrin signaling pathway. J Cell Sci, 115:2151-63.
11. Disatnik MH, Rando TA. 1999. Integrin-mediated muscle cell spreading. The role of protein kinase c in outside-in and inside-out signaling and evidence of integrin cross-talk. J Biol Chem, 274:32486-92.
12. Downward J. 2004. PI 3-kinase, Akt and cell survival. Semin Cell Dev Biol, 15:177-82.
13. Florini JR, Ewton DZ, Coolican SA. 1996. Growth hormone and the insulin-like growth factor system in myogenesis. Endocr Rev, 17:481-517.
14. Heszele MF, Price SR. 2004. Insulin-like growth factor I: the yin and yang of muscle atrophy. Endocrinology, 145:4803-5.
15. Husmann I, Soulet L, Gautron J, et al. 1996. Growth factors in skeletal muscle regeneration. Cytokine Growth Factor Rev, 7:249-58.
16. Jakubowiak A, Pouponnot C, Berguido F, et al. 2000. Inhibition of the transforming growth factor beta 1 signaling pathway by the AML1/ETO leukemia-associated fusion protein. J Biol Chem, 275:40282-7.
17. Latres E, Amini AR, Amini AA, et al. 2005. Insulin-like growth factor-1 (IGF-1) inversely regulates atrophy-induced genes via the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin (PI3K/Akt/mTOR) pathway. J Biol Chem, 280:2737-44.
18. Lawlor MA, Rotwein P. 2000. Coordinate control of muscle cell survival by distinct insulin-like growth factor activated signaling pathways. J Cell Biol, 151:1131-40.
19. Maley MA, Fan Y, Beilharz MW, et al. 1994. Intrinsic differences in MyoD and myogenin expression between primary cultures of SJL/J and BALB/C skeletal muscle. Exp Cell Res, 211:99-107.
20. Massague J, Blain SW, Lo RS. 2000. TGFbeta signaling in growth control, cancer, and heritable disorders. Cell, 103:295-309.
21. Massague J, Chen YG. 2000. Controlling TGF-beta signaling. Genes Dev, 14:627-44.
22. McCroskery S, Thomas M, Maxwell L, et al. 2003. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol, 162:1135-47.
23. McPherron AC, Lawler AM, Lee SJ. 1997. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature, 387:83-90.
24. Miller KJ, Thaloor D, Matteson S, et al. 2000. Hepatocyte growth factor affects satellite cell activation and differentiation in regenerating skeletal muscle. Am J Physiol Cell Physiol, 278:C174-181.
25. Morgan JE, Partridge TA. 2003. Muscle satellite cells. Int J Biochem Cell Biol, 35:1151-6.
26. Moustakas A, Pardali K, Gaal A, et al. 2002. Mechanisms of TGF-beta signaling in regulation of cell growth and differentiation. Immunol Lett, 82:85-91.
27. Partridge TA. 2004. Stem cell therapies for neuromuscular diseases. Acta Neurol Belg, 104:141-7.
28. Pola R, Ling LE, Aprahamian TR, et al. 2003. Postnatal recapitulation of embryonic hedgehog pathway in response to skeletal muscle ischemia. Circulation, 108:479-85.
29. Sandri M, Sandri C, Gilbert A, et al. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell, 117:399-412.
30. Schultz E, Lipton BH. 1982. Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech Ageing Dev, 20:377-83.
31. Seale P, Polesskaya A, Rudnicki MA. 2003. Adult stem cell specification by Wnt signaling in muscle regeneration. Cell Cycle, 2:418-19.
32. Shavlakadze T, White JD, Davies M. et al. 2005. Insulin-like growth factor I slows the rate of denervation induced skeletal muscle atrophy. Neuromuscul Disord, 15:139-46.
33. Sherwood RI, Christensen JL, Conboy IM, et al. 2004. Isolation of adult mouse myogenic progenitors: functional heterogeneity of cells within and engrafting skeletal muscle. Cell, 119:543-54.
34. Stitt TN, Drujan D, Clarke BA, et al. 2004. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell, 14:395-403.
35. Taverna D, Disatnik MH, Rayburn H, et al. 1998. Dystrophic muscle in mice chimeric for expression of alpha5 integrin. J Cell Biol, 143:849-59.
36. Thomas M, Langley B, Berry C, et al. 2000. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem, 275:40235-43.
37. Tidball JG. 2005. Inflammatory processes in muscle injury and repair. Am J Physiol Regul Integr Comp Physiol, 288:345-53.
38. Wagers AJ, Conboy IM 2005. Cellular and molecular signatures of muscle regeneration: current concepts and controversies in adult myogenesis. Cell, 122:659-67.
39. Yang JT, Rando TA, Mohler WA, et al. 1996. Genetic analysis of alpha 4 integrin functions in the development of mouse skeletal muscle. J Cell Biol, 135:829-35.
40. Zaidel-Bar R, Cohen M, Addadi L, et al. 2004. Hierarchical assembly of cell-matrix adhesion complexes. Biochem Soc Trans, 32:416-20.
41. Zammit PS, Heslop L, Hudon V, et al. 2002. Kinetics of myoblast proliferation show that resident satellite cells are competent to fully regenerate skeletal muscle fibers. Exp Cell Res, 281:39-49.
42. Zimmers TA, Davies MV, Koniaris LG, et al. J. 2002. Induction of cachexia in mice by systemically administered myostatin. Science, 296:1486-8.